Vice President, Marketing

Role: Lead commercial strategy and launch readiness for KT-621, a novel oral protein degrader for immune-mediated diseases, as part of Kymera's first major product launch. Responsibilities: develop and execute global commercial plans, define product positioning and value proposition, lead U.S. launch activities, craft disease-specific marketing strategies, partner with insights teams for market intelligence, influence clinical development strategies, and evaluate expansion opportunities. Qualifications: advanced degree (MBA, PharmD, PhD, MD, MPH); 15+ years in biotech/pharma commercial roles with experience in immunology, atopic dermatitis, and ideally asthma; proven success in late-stage development and U.S. launches; deep knowledge of specialty physician markets and payer dynamics. High-value specifics: focus on immunology, atopic dermatitis, and asthma; late-stage development and launch; cross-functional collaboration across Clinical, Medical, Market Access, Regulatory, and Commercial teams. Leadership competencies include strategic thinking, executive communication, cross-functional influence, data-driven decision-making, and team development. Work setup: not specified; likely hybrid or onsite given senior leadership scope.